Older Adults with Multiple Sclerosis: Issues of Aging and Disease
The study highlights that older adults with multiple sclerosis (MS) experience complex issues due to the interaction between MS and age-related changes, complicating assessment and treatment. It notes that biological aging factors like immune dysregulation may influence MS progression, leading to chronic inflammation, impaired remyelination, and neurodegeneration. Cognitive impairments, such as issues with attention and processing speed, appear early and differ from other age-related neurodegene
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Not graded
- Outcome
- Not reported
Why it matters
Understanding the interplay between aging and MS is crucial for developing appropriate assessments and treatments. Recognizing that cognitive impairments in MS occur early can help differentiate it from other neurodegenerative disorders, allowing for targeted interventions and improved patient care.
What this does not prove
The study does not provide new clinical data or results regarding direct treatment efficacy for MS in older adults, which limits its practical application in clinical settings.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-05-18
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceAge-Related Changes in Multiple Sclerosis Pathophysiology and Clinical Function. ↗DOI: 10.7224/1537-2073.2025-089
Supporting passages (7)
findingsOlder adults with multiple sclerosis (MS) face unique issues related to the combined effects of MS and age-related changes, which often present with overlapping symptoms that complicate assessment and treatment decisions.
findingsFeatures of biological aging include cellular senescence and immune dysregulation, which may drive disease progression in MS through a variety of proinflammatory mediators that may maintain low levels of chronic inflammation in the immune and central nervous system compartments and offset regulatory processes, ultimately impairing remyelination and increasing neurodegeneration.
findingsCharacteristics of cognitive impairments in MS affecting attention and processing speed occur early in the disease course and are distinct from other age-associated neurodegenerative disorders, such as Alzheimer disease, that commonly affect language and executive function domains.
publication datePublication date: 2026-05-18
limitationsTitle: Age-Related Changes in Multiple Sclerosis Pathophysiology and Clinical Function.
peer reviewedPublication types: Journal Article
subjectsOlder adults with multiple sclerosis (MS) face unique issues related to the combined effects of MS and age-related changes, which often present with overlapping symptoms that complicate assessment and treatment decisions.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.